News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
871,449 Results
Type
Article (88073)
Company Profile (825)
Press Release (782532)
Multimedia
Podcasts (200)
Webinars (29)
Section
Business (233313)
Career Advice (4149)
Deals (39887)
Drug Delivery (151)
Drug Development (91449)
Employer Resources (205)
FDA (18408)
Job Trends (17434)
News (398020)
Policy (39978)
Tag
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (3016)
Academic (2)
Accelerated approval (35)
Adcomms (36)
Allergies (154)
Alliances (56982)
ALS (183)
Alzheimer's disease (1810)
Antibody-drug conjugate (ADC) (357)
Approvals (18596)
Artificial intelligence (650)
Autoimmune disease (177)
Automation (41)
Bankruptcy (406)
Best Places to Work (12634)
BIOSECURE Act (23)
Biosimilars (206)
Biotechnology (490)
Bladder cancer (165)
Brain cancer (66)
Breast cancer (680)
Cancer (5149)
Cardiovascular disease (455)
Career advice (3573)
Career pathing (42)
CAR-T (314)
CDC (59)
Celiac Disease (2)
Cell therapy (856)
Cervical cancer (38)
Clinical research (77179)
Collaboration (1879)
Company closure (5)
Compensation (1195)
Complete response letters (75)
COVID-19 (2996)
CRISPR (101)
C-suite (914)
Cystic fibrosis (155)
Data (6412)
Decentralized trials (2)
Denatured (74)
Depression (153)
Diabetes (542)
Diagnostics (7262)
Digital health (54)
Diversity (13)
Diversity, equity & inclusion (49)
Drug discovery (317)
Drug pricing (227)
Drug shortages (36)
Duchenne muscular dystrophy (247)
Earnings (100382)
Editorial (67)
Employer branding (25)
Employer resources (174)
Events (135322)
Executive appointments (1048)
FDA (21670)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (11)
Frontotemporal dementia (24)
Funding (1592)
Gene editing (221)
Generative AI (69)
Gene therapy (692)
GLP-1 (1147)
Government (5459)
Grass and pollen (8)
Guidances (387)
Healthcare (20960)
HIV (66)
Huntington's disease (50)
IgA nephropathy (88)
Immunology and inflammation (302)
Immuno-oncology (66)
Indications (111)
Infectious disease (3297)
Inflammatory bowel disease (208)
Inflation Reduction Act (17)
Influenza (127)
Intellectual property (258)
Interviews (816)
IPO (17966)
IRA (61)
Job creations (5201)
Job search strategy (2867)
JPM (71)
Kidney cancer (18)
Labor market (96)
Layoffs (661)
Leadership (41)
Legal (10163)
Liver cancer (99)
Longevity (16)
Lung cancer (692)
Lymphoma (387)
Machine learning (45)
Management (66)
Manufacturing (882)
MASH (178)
Medical device (15061)
Medtech (15118)
Mergers & acquisitions (23011)
Metabolic disorders (1437)
Multiple sclerosis (170)
NASH (23)
Neurodegenerative disease (366)
Neuropsychiatric disorders (105)
Neuroscience (3167)
Neurotech (1)
NextGen: Class of 2026 (7709)
Non-profit (5118)
Now hiring (68)
Obesity (700)
Opinion (337)
Ovarian cancer (171)
Pain (219)
Pancreatic cancer (239)
Parkinson's disease (303)
Partnered (39)
Patents (523)
Patient recruitment (514)
Peanut (61)
People (67018)
Pharmaceutical (145)
Pharmacy benefit managers (33)
Phase 1 (23847)
Phase 2 (33491)
Phase 3 (25225)
Pipeline (5446)
Policy (343)
Postmarket research (3554)
Preclinical (10701)
Press Release (72)
Prostate cancer (254)
Psychedelics (58)
Radiopharmaceuticals (305)
Rare diseases (947)
Real estate (7442)
Recruiting (81)
Regulatory (29161)
Reports (68)
Research institute (2733)
Resumes & cover letters (652)
Rett syndrome (28)
RNA editing (21)
RSV (86)
Schizophrenia (162)
Series A (263)
Series B (204)
Service/supplier (30)
Sickle cell disease (105)
Special edition (27)
Spinal muscular atrophy (178)
Sponsored (48)
Startups (4336)
State (2)
Stomach cancer (20)
Supply chain (114)
Tariffs (101)
The Weekly (124)
Vaccines (1172)
Venture capital (100)
Weight loss (482)
Women's health (96)
Worklife (22)
Date
Last 7 days (668)
Last 30 days (2223)
Last 365 days (32719)
2026 (3761)
2025 (33229)
2024 (38141)
2023 (42567)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51337)
2018 (39122)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1290)
Alabama (92)
Alaska (7)
Arizona (348)
Arkansas (14)
Asia (51630)
Australia (9067)
California (11789)
Canada (3386)
China (1202)
Colorado (501)
Connecticut (512)
Delaware (355)
Europe (118646)
Florida (1741)
Georgia (378)
Hawaii (4)
Idaho (68)
Illinois (981)
India (73)
Indiana (554)
Iowa (24)
Japan (448)
Kansas (134)
Kentucky (43)
Louisiana (30)
Maine (83)
Maryland (1476)
Massachusetts (8666)
Michigan (368)
Minnesota (675)
Mississippi (6)
Missouri (143)
Montana (36)
Nebraska (29)
Nevada (128)
New Hampshire (86)
New Jersey (3165)
New Mexico (33)
New York (3110)
North Carolina (1639)
North Dakota (10)
Northern California (5668)
Ohio (361)
Oklahoma (23)
Oregon (55)
Pennsylvania (2349)
Puerto Rico (25)
Rhode Island (51)
South America (1665)
South Carolina (68)
South Dakota (1)
Southern California (4554)
Tennessee (180)
Texas (1860)
United States (42485)
Utah (352)
Vermont (1)
Virginia (296)
Washington D.C. (88)
Washington State (989)
West Virginia (4)
Wisconsin (133)
Wyoming (2)
871,449 Results for "'".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Restart Life Sciences Executes Definitive Agreement to Acquire Holy Crap Foods
February 13, 2026
·
6 min read
Earnings
Moderna’s FDA Challenges Stymie Breakeven Goal in ‘Fresh and Fluid’ Situation
Moderna will not commit to previous 2028 breakeven guidance as the ripple effects of the FDA’s refusal-to-file decision spread through its pipeline.
February 13, 2026
·
5 min read
·
Annalee Armstrong
Gene therapy
Vertex, CRISPR Set Lofty Goal for Casgevy Gene Therapy as Patient Starts Ramp
Following over a year of slow uptake, Vertex Pharmaceuticals and CRISPR Therapeutics expect Casgevy revenues to nearly triple in 2026, as patient access to the sickle cell disease and beta thalassemia gene therapy grows.
February 13, 2026
·
3 min read
·
Dan Samorodnitsky
Press Releases
Cellular Telomere Extension Technology: Can It Become a Core Platform for the Anti-Aging Industry? - Commentary by Unexakorea
February 13, 2026
·
1 min read
Press Releases
Soin Neuroscience and Lilac Biosciences Launch Collaboration to Study RNA Signatures in Pain and Neuromodulation
February 13, 2026
·
3 min read
Press Releases
Precision Biologics’ New PB-223 ADC Targeting Multiple Cancer Types to Be Highlighted in Keynote at 6th ACE Drug Discovery Summit
February 13, 2026
·
1 min read
Press Releases
Altamira Therapeutics Announces Allowance of Japanese Patent Application Covering Bentrio Nasal Spray
February 13, 2026
·
5 min read
Press Releases
HCW Biologics and WY Biotech Announce Closing of First Round of Financing For Newly Formed Joint Venture Trimmune
February 13, 2026
·
10 min read
Press Releases
Moleculin Launches CEO Corner Platform to Share Strategic Insights
February 13, 2026
·
4 min read
Press Releases
MEDIPOST Inc. Submits IND Amendment With U.S. Food and Drug Administration to Initiate Phase III Trial
February 13, 2026
·
1 min read
1 of 87,145
Next
